연구성과로 돌아가기

2023 연구자 정보 (424 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Windhorst, Rogier A.
(Windhorst, RA) ⓘ 		Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA ⓘ
ⓘ
ⓘ 		[JCR상위 11.3] The JCMT SCUBA-2 Survey of the James Webb Space Telescope North Ecliptic Pole Time-Domain Field ⓘ SCIE ⓘ 11.3 ASTRONOMY & ASTROPHYSICS ⓘ minhee@kasi.re.kr;myungshin.im@gmail.com; ⓘ
Woo, Jong-Hak
(Woo, JH) ⓘ 		Seoul Natl Univ, Dept Phys & Astron, Seoul 08826, South Korea
Seoul Natl Univ, Dept Phys & Astron, Astron Program, 1 Gwanak Ro, Seoul 08826, South Korea
Seoul Natl Univ, SNU Astron Res Ctr, 1 Gwanak Ro, Seoul 08826, South Korea ⓘ 		A-2790-2014
Woo, Jong-Hak ⓘ
ⓘ 		[JCR상위 11.3] Photometric Selection of Unobscured QSOs at the Ecliptic Poles: KMTNet in the South Field and Pan-STARRS in the North Field
[JCR상위 17.3] The Seoul National University AGN Monitoring Project. IV. Hα Reverberation Mapping of Six AGNs and the Hα Size-Luminosity Relation
[JCR상위 17.3] What Does the Geometry of the Hβ BLR Depend On? ⓘ 		SCIE ⓘ 11.3 ASTRONOMY & ASTROPHYSICS ⓘ wbyun87@gmail.com;mkim@knu.ac.kr;
woo@astro.snu.ac.kr;
lvillafana@astro.ucla.edu; ⓘ
Yan, Haojing
(Yan, HJ) ⓘ 		Univ Missouri, Dept Phys & Astron, Columbia, MO 65211 USA ⓘ
ⓘ
ⓘ 		[JCR상위 11.3] The JCMT SCUBA-2 Survey of the James Webb Space Telescope North Ecliptic Pole Time-Domain Field ⓘ SCIE ⓘ 11.3 ASTRONOMY & ASTROPHYSICS ⓘ minhee@kasi.re.kr;myungshin.im@gmail.com; ⓘ
Yang, Yujin
(Yang, Y) ⓘ 		Korea Astron & Space Sci Inst, Daejeon 34055, South Korea
Univ Sci & Technol, Daejeon 34113, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 11.3] Photometric Selection of Unobscured QSOs at the Ecliptic Poles: KMTNet in the South Field and Pan-STARRS in the North Field ⓘ SCIE ⓘ 11.3 ASTRONOMY & ASTROPHYSICS ⓘ wbyun87@gmail.com;mkim@knu.ac.kr; ⓘ
Yu, HongBi
(Yu, H) ⓘ 		Sungkyunkwan Univ Sch, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 11.3] Allelic Enhancement of BEL.02 With the Single Nucleotide Variant, c.669G>T ⓘ SCIE ⓘ 11.3 MEDICAL LABORATORY TECHNOLOGY ⓘ marta10@hanmail.net;duck.cho@skku.edu; ⓘ
Avagyan, H.
(Avagyan, H) ⓘ 		Thomas Jefferson Natl Accelerator Facil, Newport News, VA USA
Thomas Jefferson Natl Accelerator Facil, Newport News, VA 23606 USA ⓘ
ⓘ
ⓘ 		[JCR상위 11.4] A multidimensional study of the structure function ratio σLT''/σ0 from hard exclusive π± electro-production off protons in the GPD regime
[JCR상위 2.3] Precision studies of QCD in the low energy domain of the EIC ⓘ 		SCIE ⓘ 2.3 ASTRONOMY & ASTROPHYSICS;PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS
PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS ⓘ 		stefan.diehl@exp2.physik.uni-giessen.de;
burkert@jlab.org; ⓘ
Cho, Yong-Soon
(Cho, YS) ⓘ 		제1저자 Inje Univ, Coll Med, Dept Pharmacol, Busan, South Korea
Inje Univ, Coll Med, PharmacoGen Res Ctr, Busan, South Korea
Inje Univ, Coll Med, Ctr Personalized Precis Med TB, Busan, South Korea
Inje Univ, Busan Paik Hosp, Dept Clin Pharmacol, Busan, South Korea
Inje Univ, Ctr Personalized Precis Med TB CPMTb, Coll Med, Busan, South Korea
Inje Univ, Dept Pharmacol, Coll Med, Busan, South Korea
Inje Univ, PharmacoGen Res Ctr, Coll Med, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study
[JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort ⓘ 		SCIE ⓘ 11.4 RESPIRATORY SYSTEM ⓘ ⓘ
Choi, Chang Min
(Choi, CM) ⓘ 		Univ Ulsan, Asan Med Ctr, Internal Med, Coll Med, Seoul, South Korea
Univ Ulsan, Asan Med Ctr, Dept Pulm & Crit Care Med, Coll Med, Seoul, South Korea
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul 05505, South Korea
Ulsan Univ, Dept Internal Med, Asan Med Ctr, Seoul, South Korea
Univ Ulsan, Asan Med Ctr, Coll Med, Dept Internal Med, Seoul, South Korea ⓘ
ⓘ 		0000-0002-2881-4669
Choi, Chang-Min ⓘ 		[JCR상위 11.4] Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial
[JCR상위 1.5] Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KR
[JCR상위 30.5] Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial
[JCR상위 21.3] Real-world first-line afatinib for advanced EGFR mutation-positive non-small cell lung cancer in Korea: updated survival data
[JCR상위 21.3] Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
[JCR상위 28.4] Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study ⓘ 		SCIE ⓘ 1.5 RESPIRATORY SYSTEM
ONCOLOGY;RESPIRATORY SYSTEM
CELL BIOLOGY
ONCOLOGY ⓘ 		droij@jnu.ac.kr;
ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr;
jangtw22@hanmail.net;
jangtw22@hanmail.com; ⓘ
Choi, Dong-Kyu
(Choi, DK) ⓘ 		Kyungpook Natl Univ, Sch Comp Sci & Engn, 80 Daehak Ro, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 11.4] Use of QUIC for CoAP transport in IoT networks ⓘ SCIE ⓘ 11.4 COMPUTER SCIENCE, INFORMATION SYSTEMS;ENGINEERING, ELECTRICAL & ELECTRONIC;TELECOMMUNICATIONS ⓘ sjkoh@knu.ac.kr; ⓘ
Chun, Sung-Min
(Chun, SM) ⓘ 		Univ Ulsan, Asan Med Ctr, Pathol, Coll Med, Seoul, South Korea
Univ Ulsan, Asan Med Ctr, Coll Med, Dept Pathol, Seoul 05505, South Korea ⓘ
ⓘ 		0000-0002-3357-1382
Chun, Sung-Min ⓘ 		[JCR상위 11.4] Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial
[JCR상위 30.5] Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial ⓘ 		SCIE ⓘ 11.4 RESPIRATORY SYSTEM
CELL BIOLOGY ⓘ 		ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr; ⓘ
Jang, Tae-Won
(Jang, TW) ⓘ 		Kosin Univ, Gospel Hosp, Coll Med, Dept Internal Med, Busan, South Korea
Kosin Univ, Coll Med, Dept Internal Med, Gospel Hosp, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study
[JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort ⓘ 		SCIE ⓘ 11.4 RESPIRATORY SYSTEM ⓘ ⓘ
Jeon, Yeong Jun
(Jeon, YJ) ⓘ 		제1저자 Kyungpook Natl Univ, Coll IT Engn, Sch Elect & Elect Engn, 80 Daehak Ro, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 11.4] Self-x based closed loop wearable IoT for real-time detection and resolution of sleep apnea ⓘ SCIE ⓘ 11.4 COMPUTER SCIENCE, INFORMATION SYSTEMS;ENGINEERING, ELECTRICAL & ELECTRONIC;TELECOMMUNICATIONS ⓘ dudwns333@gmail.com;siminsungho@gmail.com;sjkang@ee.knu.ac.kr; ⓘ
Jun, Ha Ra
(Jun, HR) ⓘ 		Univ Ulsan, Asan Med Ctr, Med Sci, Coll Med, Seoul, South Korea
Univ Ulsan, Asan Med Inst Convergence Sci & Technol, Asan Med Ctr,Coll Med, Dept Med Sci, Seoul 05505, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 11.4] Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY trial
[JCR상위 30.5] Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial ⓘ 		SCIE ⓘ 11.4 RESPIRATORY SYSTEM
CELL BIOLOGY ⓘ 		ckpark214@jnu.ac.kr;3143137@naver.com;ohj4250@naver.com;easy0@hanmail.net;repair2799@hanmail.net;kyc0923@jnu.ac.kr;jelee0210@cnu.ac.kr;dognose79@naver.com;ccm9607@gmail.com;jclee@amc.seoul.kr;syl0801@korea.ac.kr;shinyup@knu.ac.kr;smchun@amc.seoul.kr;droij@jnu.ac.kr; ⓘ
Jung, Joong-Hwa
(Jung, JH) ⓘ 		제1저자 Kyungpook Natl Univ, Sch Comp Sci & Engn, 80 Daehak Ro, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 11.4] Use of QUIC for CoAP transport in IoT networks ⓘ SCIE ⓘ 11.4 COMPUTER SCIENCE, INFORMATION SYSTEMS;ENGINEERING, ELECTRICAL & ELECTRONIC;TELECOMMUNICATIONS ⓘ sjkoh@knu.ac.kr; ⓘ
Kim, Ho Cheol
(Kim, HC) ⓘ 		Gyeongsang Natl Univ, Changwon Hosp, Dept Internal Med, Div Pulmonol & Allergy, Jinju, South Korea
Gyeongsang Natl Univ, Div Pulmonol & Allergy, Dept Internal Med, Changwon Hosp, Gyeongsang, South Korea ⓘ 		F-6278-2013
Kim, Cheol-Hee ⓘ
ⓘ 		[JCR상위 11.4] Distribution of drug exposure and pharmacokinetic/pharmacodynamic predictor of first-line anti-TB drugs in a Korean prospective cohort study
[JCR상위 11.4] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort ⓘ 		SCIE ⓘ 11.4 RESPIRATORY SYSTEM ⓘ ⓘ
페이지 이동: